In a significant development for investors, The Law Offices of Frank R. Cruz has announced an investigation into Inspire Medical Systems, Inc. (NYSE: INSP) over potential violations of federal securities laws. This investigation comes on the heels of troubling disclosures regarding the company's operations and financial guidance, which have led to a dramatic decline in stock value.

2. Background on Inspire Medical Systems

Inspire Medical Systems specializes in innovative solutions for obstructive sleep apnea (OSA), notably with the development of its Inspire V device. This product was anticipated to bolster the company’s market presence and financial performance, but recent announcements have raised serious concerns among shareholders.

3. Key Issues Leading to Investigation

On August 4, 2025, Inspire revealed that the launch of its new Inspire V device would face a prolonged delay due to several operational challenges. Among the most pressing issues cited were:

Training and Onboarding Delays: Many medical centers had not completed the necessary training and onboarding processes required before they could purchase and implant the Inspire V device.

Software Update Delays: The company disclosed that critical software updates necessary for claims submissions and processing would not be implemented until early July, further complicating the rollout of the new device.

Excess Inventory: Inspire faced a build-up of inventory that significantly dampened demand for the Inspire V, raising questions about the product's market acceptance.

In light of these revelations, Inspire also slashed its earnings guidance for 2025 by more than 80%, revising the expected earnings per share from a range of $2.20 to $2.30 down to just $0.40 to $0.50. This drastic adjustment sent shockwaves through the investor community.

4. Stock Price Impact

Following the alarming announcement, Inspire Medical Systems' stock plummeted, falling $42.04, or 32.4%, to close at $87.91 per share on August 5, 2025. The steep decline in share price has raised serious concerns over the company's operational integrity and management's communication with investors.

5. Call to Action for Affected Investors

The Law Offices of Frank R. Cruz is urging shareholders who have suffered financial losses as a result of Inspire's recent disclosures to come forward. Investors who purchased shares of Inspire Medical Systems and believe they may have been misled or harmed by the company’s actions are encouraged to reach out to the firm for more information and potential participation in legal claims.

6. Conclusion

The investigation into Inspire Medical Systems serves as a critical reminder of the importance of transparency and accountability in corporate governance. With the company facing a challenging operational landscape and a significant decline in investor confidence, stakeholders will be closely monitoring future developments. The outcome of this investigation could have profound implications not only for Inspire but also for the broader market perception of companies within the medical technology sector.

Investors are urged to stay informed about their rights and the ongoing developments in this situation.

Original press release